The US menopause market is massive and if affected women can be given another option then that is great. Let's hope of continued success for Donesta and that Mithra and Mayne Pharma can do another deal and build on the significant marketing and distribution capability already established for Nextstellis.
- Forums
- ASX - By Stock
- MYX
- Mithra’s Donesta phase 3 trial results
MYX
mayne pharma group limited
Add to My Watchlist
1.15%
!
$5.15

Mithra’s Donesta phase 3 trial results, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.15 |
Change
-0.060(1.15%) |
Mkt cap ! $411.9M |
Open | High | Low | Value | Volume |
$5.22 | $5.25 | $5.07 | $448.3K | 86.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1146 | $5.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 420 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1138 | 5.120 |
4 | 2890 | 5.110 |
4 | 1893 | 5.100 |
4 | 1253 | 5.090 |
3 | 1068 | 5.080 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 1282 | 4 |
5.160 | 1808 | 3 |
5.170 | 1614 | 4 |
5.180 | 1788 | 3 |
5.190 | 1281 | 4 |
Last trade - 12.23pm 23/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |